MedPath

The effect of synbiotic on burn infections

Phase 3
Conditions
patient with major burn 25-50 percent.
Registration Number
IRCT20190423043354N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
170
Inclusion Criteria

Burn percent 25-50
No use of any prebiotic, probiotic or synbiotic in last 2 months before the study starts
Patients with stable condition

Exclusion Criteria

Use of dopamine and epinephrine
Pregnancy and breast feeding
Allergy to melatonin
Bowel obstruction - ileus - gastroparesy or any condition that affect enteral absorption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positive sputum culture. Timepoint: After 15 days of synbiotic or placebo prescription. Method of measurement: Sputum culture.;Positive blood culture. Timepoint: After 15 days of synbiotic or placebo prescription. Method of measurement: Blood culture.;Positive urinary culture. Timepoint: After 15 days of synbiotic or placebo prescription. Method of measurement: Urinary culture.;Positive catheter infection. Timepoint: After 15 days of synbiotic or placebo prescription. Method of measurement: Clinician examination - catheter culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath